Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Passes Above 50 Day Moving Average – Here’s What Happened

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF)’s share price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $10.63 and traded as high as $11.50. Ono Pharmaceutical shares last traded at $11.50, with a volume of 11,572 shares traded.

Ono Pharmaceutical Trading Up 0.4 %

The company’s fifty day simple moving average is $10.60 and its two-hundred day simple moving average is $12.70.

Ono Pharmaceutical (OTCMKTS:OPHLF) last issued its quarterly earnings data on Thursday, October 31st. The company reported $0.24 earnings per share (EPS) for the quarter. The business had revenue of $824.42 million for the quarter. Ono Pharmaceutical had a return on equity of 11.80% and a net margin of 19.64%. As a group, equities research analysts anticipate that Ono Pharmaceutical Co., Ltd. will post 1.24 earnings per share for the current fiscal year.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.